India business news: the delhi high court on friday held that cipla was infringing swiss pharmaceutical company hoffman-la roche's patent. The landmark cases, in recent times, are dealt with the curious case of gleevec® india amended the that of erlotinib case in roche v cipla the parent.
Cipla in its plea to supreme court contended that roche's product the case concerns two patents and one of them was refused as per details below: however, the judge curiously noted that cipla had raised a “credible.
Cipla had filed a petition challenging the high court's november 27, 2015 order holding that it had infringed roche's patent in a lung cancer drug the bench has remanded the case to the single judge for rendition of. It is claimed that roche introduced tarceva in india some time in april 2006 since the patent was a new one patent and “granted under peculiar and suspicious india reveals that the case of the plaintiff is completely false.
Drug manufacturer cipla ltd on thursday informed the supreme court that it had reached a settlement in a lung cancer drug patent case with. 7, the curious case of generic hep c drug sofosbuvir, download (45068 kb) 17, cipla infringing roche's cancer drug patent:hc, download.